Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.946    0.002 (0.21%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Biopharma Cred. News

BioPharma Credit agrees loan agreement with subsidiary for Immunocore
21 Nov 2022

BioPharma Credit agrees loan agreement with subsidiary for Immunocore

(Alliance News) - BioPharma Credit PLC said on Monday it has entered into a definitive senior secured loan agreement with its fully-owned subsidiary B...

BioPharma makes investment in Insmed for disease therapy development
20 Oct 2022

BioPharma makes investment in Insmed for disease therapy development

(Alliance News) - BioPharma Credit PLC on Thursday said it has made a USD140.0 million investment in US biopharmaceutical company Insmed Inc for the d...

IN BRIEF: BioPharma Credit pays special dividend; NAV increases
13 Oct 2022

IN BRIEF: BioPharma Credit pays special dividend; NAV increases

BioPharma Credit PLC - Winchester, England-based life sciences debt investment trust - Declares an interim dividend of USD0.0625 for its third quarter...

IN BRIEF: BioPharma Credit receives USD175 million from Pfizer deal
6 Oct 2022

IN BRIEF: BioPharma Credit receives USD175 million from Pfizer deal

Biopharma Credit PLC - New York-based life sciences debt investment trust - Company's investment manager, Pharmakon Advisors, notes the announcement m...

BioPharma Credit net asset value and half-year profit both rise
14 Sep 2022

BioPharma Credit net asset value and half-year profit both rise

(Alliance News) - BioPharma Credit PLC on Wednesday posted a slightly higher net asset value as profit shot up on the back of increased investment.

IN BRIEF: BioPharma Credit says Epizyme investment repaid amid buyout
22 Aug 2022

IN BRIEF: BioPharma Credit says Epizyme investment repaid amid buyout

BioPharma Credit PLC - life sciences debt investment trust - Says had USD110 million investment in Epizyme Inc in form of senior secured loan. "The lo...

IN BRIEF: BioPharma Credit may benefit as Pfizer buys investee GBT
9 Aug 2022

IN BRIEF: BioPharma Credit may benefit as Pfizer buys investee GBT

BioPharma Credit PLC - life sciences debt investment trust - Says it has USD132.5 million investment in Global Blood Therapeutics Inc, a company which...